目次

Table of Contents

Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Service
1.1.2. End-use
1.1.3. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.2. Volume price analysis (Model 2)
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
1.9.1. Objective 1
1.9.2. Objective 2
1.9.3. Objective 3
1.9.4. Objective 4

Chapter 2. Executive Summary
2.1. Market Outlook

Chapter 3. Pharmaceutical Contract Sales Organization Market (CSO) Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Increase the R&D activities on drugs and increase in the drug pipeline
3.2.1.2. Growing interest of pharmaceutical companies to increase the sales of the products
3.2.1.3. Adoption of digital technologies by Pharmaceutical Contract Sales Organizations
3.2.2. Market restraint analysis
3.2.2.1. Quality issues associated with outsourcing
3.2.3. Covid-19 Impact & Recovery Analysis
3.2.4. Industry Analysis - Porter’s Five Forces
3.2.5. PESTLE Analysis

Chapter 4. Pharmaceutical Contract Sales Organization Market (CSO): Service Segment Analysis
4.1. Pharmaceutical Contract Sales Organization Market (CSO) Market: Definition & Scope
4.2. Pharmaceutical Contract Sales Organization Market (CSO) Market: Service Market Share Analysis, 2022 & 2030
4.2.1. Personal Promotion
4.2.1.1. Personal promotion market, 2018 - 2030 (USD Million)
4.2.1.2. Promotional sales team
4.2.1.2.1. Promotional sales team market, 2018 - 2030 (USD Million)
4.2.1.3. Key account management
4.2.1.3.1. Key account management market, 2018 - 2030 (USD Million)
4.2.1.4. Vacancy Management
4.2.1.4.1. Vacancy Management market, 2018 - 2030 (USD Million)
4.2.2. Non-Personal Promotion
4.2.2.1. Non-Personal promotion market, 2018 - 2030 (USD Million)
4.2.2.2. Medical affairs solutions
4.2.2.2.1. Medical affairs solutions market, 2018 - 2030 (USD Million)
4.2.2.3. Remote medical science liaisons
4.2.2.3.1. Remote medical science liaisons market, 2018 - 2030 (USD Million)
4.2.2.4. Nurse (clinical) educators
4.2.2.4.1. Nurse (clinical) educators market, 2018 - 2030 (USD Million)
4.2.2.5. Others
4.2.2.5.1. Others market, 2018 - 2030 (USD Million)

Chapter 5. Pharmaceutical Contract Sales Organization Market (CSO): End-use Segment Analysis
5.1. Pharmaceutical Contract Sales Organization Market (CSO) Market: Definition & Scope
5.2. Pharmaceutical Contract Sales Organization Market (CSO) Market: End Use Market Share Analysis, 2022 & 2030
5.2.1. Pharmaceutical Companies
5.2.1.1. Pharmaceutical companies Market, 2018 - 2030 (USD Million)
5.2.2. Biopharmaceutical Companies
5.2.2.1. Biopharmaceutical companies Market, 2018 - 2030 (USD Million)

Chapter 6. Pharmaceutical Contract Sales Organization Market (CSO): Regional Analysis
6.1. Pharmaceutical Contract Sales Organization Market (CSO): Regional market share analysis, 2022 & 2030
6.2. North America
6.2.1. North America Market estimates and forecast, 2018 - 2030
6.2.2. U.S.
6.2.2.1. U.S. Market estimates and forecast, 2018 - 2030
6.2.3. Canada
6.2.3.1. Canada Market estimates and forecast, 2018 - 2030
6.3. Europe
6.3.1. Europe Market estimates and forecast, 2018 - 2030
6.3.2. U.K.
6.3.2.1. U.K. Market estimates and forecast, 2018 - 2030
6.3.3. Germany
6.3.3.1. Germany Market estimates and forecast, 2018 - 2030
6.3.4. France
6.3.4.1. France Market estimates and forecast, 2018 - 2030
6.3.5. Italy
6.3.5.1. Italy Market estimates and forecast, 2018 - 2030
6.3.6. Spain
6.3.6.1. Spain Market estimates and forecast, 2018 - 2030
6.3.7. Denmark
6.3.7.1. Denmark Market estimates and forecast, 2018 - 2030
6.3.8. Sweden
6.3.8.1. Sweden Market estimates and forecast, 2018 - 2030
6.3.9. Norway
6.3.9.1. Norway Market estimates and forecast, 2018 - 2030
6.4. Asia Pacific
6.4.1. Asia Pacific Market estimates and forecast, 2018 - 2030
6.4.2. Japan
6.4.2.1. Japan Market estimates and forecast, 2018 - 2030
6.4.3. China
6.4.3.1. China Market estimates and forecast, 2018 - 2030
6.4.4. India
6.4.4.1. India Market estimates and forecast, 2018 - 2030
6.4.5. South Korea
6.4.5.1. South Korea Market estimates and forecast, 2018 - 2030
6.4.6. Australia
6.4.6.1. Australia Market estimates and forecast, 2018 - 2030
6.4.7. Thailand
6.4.7.1. Thailand Market estimates and forecast, 2018 - 2030
6.5. Latin America
6.5.1. Latin America Market estimates and forecast, 2018 - 2030
6.5.2. Brazil
6.5.2.1. Brazil Market estimates and forecast, 2018 - 2030
6.5.3. Mexico
6.5.3.1. Mexico Market estimates and forecast, 2018 - 2030
6.5.4. Argentina
6.5.4.1. Argentina Market estimates and forecast, 2018 - 2030
6.6.MEA
6.6.1. MEA Market estimates and forecast, 2018 - 2030
6.6.2. South Africa
6.6.2.1. South Africa Market estimates and forecast, 2018 - 2030
6.6.3. Saudi Arabia
6.6.3.1. Saudi Arabia Market estimates and forecast, 2018 - 2030
6.6.4. UAE
6.6.4.1. UAE Market estimates and forecast, 2018 - 2030
6.6.5. Kuwait
6.6.5.1. Kuwait Market estimates and forecast, 2018 - 2030

Chapter 7. Competitive Landscape
7.1. CMIC HOLDINGS Co., LTD
7.1.1.1. Company overview
7.1.1.2. Financial performance
7.1.1.3. Service benchmarking
7.1.1.4. Strategic initiatives
7.2. Axxelus
7.2.1.1. Company overview
7.2.1.2. Financial performance
7.2.1.3. Service benchmarking
7.2.1.4. Strategic initiatives
7.3. EPS Corporation.
7.3.1.1. Company overview
7.3.1.2. Financial performance
7.3.1.3. Service benchmarking
7.3.1.4. Strategic initiatives
7.4. QFR SOLUTIONS
7.4.1.1. Company overview
7.4.1.2. Financial performance
7.4.1.3. Service benchmarking
7.4.1.4. Strategic initiatives
7.5. MaBico
7.5.1.1. Company overview
7.5.1.2. Financial performance
7.5.1.3. Service benchmarking
7.5.1.4. Strategic initiatives
7.6. Mednext Pharma Private Limited
7.6.1.1. Company overview
7.6.1.2. Financial performance
7.6.1.3. Service benchmarking
7.6.1.4. Strategic initiatives
7.7. Peak Pharma Solutions Inc.
7.7.1.1. Company overview
7.7.1.2. Financial performance
7.7.1.3. Service benchmarking
7.7.1.4. Strategic initiatives
7.8. IQVIA, Inc.
7.8.1.1. Company overview
7.8.1.2. Financial performance
7.8.1.3. Service benchmarking
7.8.1.4. Strategic initiatives
7.9. Promoveo Health
7.9.1.1. Company overview
7.9.1.2. Financial performance
7.9.1.3. Service benchmarking
7.9.1.4. Strategic initiatives
7.10. Syneous Health
7.10.1.1. Company overview
7.10.1.2. Financial performance
7.10.1.3. Service benchmarking
7.10.1.4. Strategic initiatives

List of Tables
Table 1 List of secondary sources
Table 2 List of Abbreviations

List of Figures
Fig. 1 Market research process
Fig. 2 Information Procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 QFD modeling for market share assessment
Fig. 7 Market segmentation & scope
Fig. 8 Pharmaceutical CSO market outlook, 2018 - 2030
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (Current & future impact)
Fig. 11 Market restraint relevance analysis (Current & future impact)
Fig. 12 SWOT Analysis, By Factor (political & legal, economic and technological)
Fig. 13 Porter’s Five Forces Analysis
Fig. 14 Pharmaceutical CSO market: Service outlook key takeaways
Fig. 15 Pharmaceutical CSO market: Service movement analysis
Fig. 16 Personal Promotion market, 2018 - 2030 (USD Million)
Fig. 17 Promotional sales team market, 2018 - 2030 (USD Million)
Fig. 18 Key account management market, 2018 - 2030 (USD Million)
Fig. 19 Vacancy management market, 2018 - 2030 (USD Million)
Fig. 20 Non-personal Promotion market, 2018 - 2030 (USD Million)
Fig. 21 Medical affairs solutions market, 2018 - 2030 (USD Million)
Fig. 22 Remote medical science liaisons market, 2018 - 2030 (USD Million)
Fig. 23 Nurse (clinical) educators market, 2018 - 2030 (USD Million)
Fig. 24 Others market, 2018 - 2030 (USD Million)
Fig. 25 Pharmaceutical CSO market: End-use outlook key takeaways
Fig. 26 Pharmaceutical CSO market: End-use movement analysis
Fig. 27 Pharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 28 Biopharmaceutical companies market, 2018 - 2030 (USD Million)
Fig. 29 Regional marketplace: Key takeaway
Fig. 30 Pharmaceutical CSO market regional outlook, 2020 & 2028
Fig. 31 North America Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 32 U.S. Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 33 Canada Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 34 Europe Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 35 Germany Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 36 France Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 37 U.K. Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 38 Spain Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 39 Italy Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 40 Denmark Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 41 Sweden Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 42 Norway Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 43 Asia Pacific Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 44 Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 45 Japan Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 46 India Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 47 Thailand Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 48 South Korea Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 49 Australia Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 50 Latin America Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 51 Brazil Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 52 Mexico Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 53 Argentina Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 54 Middle East & Africa Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 55 South Africa Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 56 Saudi Arabia Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 57 UAE Pharmaceutical CSO market, 2018 - 2030 (USD Million)
Fig. 58 Kuwait Pharmaceutical CSO market, 2018 - 2030 (USD Million)